RevTek Capital
4215 E McDowell Rd, Ste 108, Mesa, Arizona, 85215, United States
Overview
Established in 2021, RevTek Capital is a boutique asset manager specializing in tailored credit solutions for SaaS technology companies and other high-growth recurring revenue businesses. Our platform provides alternative investment products for high-net-worth investors, family offices, financial advisors and institutions seeking attractive, uncorrelated returns. Since its inception, RevTek has extended over $100 million in credit. For larger investments, RevTek joins forces with co-investors who manage over $1.5 billion in assets under management (AUM). For portfolio companies, RevTek offers flexible, founder-friendly debt capital ranging from $3 million to $30 million. Our customized financing solutions are designed to maximize enterprise value while minimizing dilution and are geared toward established growth companies with a proven track record of $5 million+ in annual recurring revenue (ARR) or $1.5 million+ in EBITDA. RevTek’s founders are accomplished entrepreneurs who have successfully built and operated our own businesses. We understand the entrepreneurial mindset and structure our solutions to align RevTek’s success with the success of our borrowers. Whether you are seeking capital to fuel growth, facilitate an acquisition, bridge to the next milestone or refinance existing debt, we are eager to learn about your business and collaborate on the optimal financing solution.
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 6
Sector focus
- Finance
- Financial Services
- FinTech
- Venture Capital
Investment portfolio
- Cymbiotika LLC
Led · Debt Financing · Oct 2024
Cymbiotika produces liposomal-format supplements delivered in flavored, single-serving 5-ml liquid packs and sells a range that includes vitamin C, NAD+, magnesium, sea moss, glutathione, colostrum and liposomal elderberry. Price points noted in reporting range from about $48 for a one-month supply of Liposomal Elderberry to $88 for Liposomal Glutathione and Colostrum. The company was founded in San Diego in 2019 and reported $150 million in revenue in 2025. Cymbiotika has been expanding beyond direct-to-consumer channels, entering Target in the fall and Ulta Beauty in March as part of a stated push to build an omnichannel experience. In January the company closed a $25 million funding round with participation from artists including The Weeknd and Post Malone, and it counts several celebrity investors such as Kendall Jenner, Hailey Bieber, Zac Efron, Steve Aoki, Peggy Gou and now Alix Earle.
- Gradient Cyber
Led · Equity · Mar 2022
Gradient Cyber offers enterprises 24/7 security operations-as-a-service combined with a security intelligence platform. Its solution includes network monitoring, log ingestion, intrusion detection systems, endpoint integration, threat management, asset communication discovery, and network data anomaly detection. The security intelligence platform correlates real-time data and logs to improve transparency over risks across customer environments. Gradient Cyber provides subscription access to senior cybersecurity analysts, threat and risk assessments, and an extended detection and response (XDR) service the company says leverages ML and AI. The company focuses on helping small and mid-market enterprises outsource continuous security operations they cannot staff 24/7. Auctus Capital Partners became Gradient Cyber’s exclusive advisor and secured $10 million in financing from Revtek Capital to accelerate the company’s growth.